Baye, J. (2012). Roflumilast (Daliresp): A Novel Phosphodiesterase-4 Inhibitor for the Treatment Of Severe Chronic Obstructive Pulmonary Disease. MediMedia USA, Inc.
Chicago Style CitationBaye, Jordan. Roflumilast (Daliresp): A Novel Phosphodiesterase-4 Inhibitor for the Treatment Of Severe Chronic Obstructive Pulmonary Disease. MediMedia USA, Inc, 2012.
Cita MLABaye, Jordan. Roflumilast (Daliresp): A Novel Phosphodiesterase-4 Inhibitor for the Treatment Of Severe Chronic Obstructive Pulmonary Disease. MediMedia USA, Inc, 2012.
Atenció: Aquestes cites poden no estar 100% correctes.